|Pharmacoepidemiology Program Area|
Epidemiologists working in the area of pharmacoepidemiology apply epidemiologic reasoning, methods, and knowledge to the study of the uses and effects, beneficial and harmful, of prescription and over the counter drugs, biologics, vaccines, and medical devices in human populations.
Traditionally, pharmacoepidemiology was primarily concerned with post-marketing studies of drug safety. Over the past 15 years, it has evolved toward a broader focus on epidemiologic questions arising in drug and vaccine development and in health services research more generally, including the observational study of beneficial or intended effects. Studies of intended drug effects are also known as effectiveness studies and include comparative effectiveness research (CER) studies.
Pharmacoepidemiology research is often based on large health care utilization databases using nonexperimental study of intended and unintended drug effects outside of randomized controlled trials. The scope of pharmacoepidemiology is broad, encompassing such diverse areas as:
The Center for Pharmacoepidemiology is a unique partnership between the UNC Gillings School of Global Public Health and all entities developing, producing, marketing, delivering, or regulating drugs, biologics, vaccines, or medical devices. See CPE.
Students in the Pharmacoepidemiology Program receive training in how to conduct high-quality epidemiologic research that directly addresses both substantive and methodologic questions. Students gain experience through interdisciplinary opportunities in courses and collaborative work with researchers from the Schools of Public Health, Medicine, and Pharmacy, as well as through graduate research assistant opportunities with researchers and faculty in the Department of Epidemiology and epidemiology researchers working with GSK, Merck and other industry partners. Through fellowships and internships, students learn how to engage with industry and government stakeholders and become exposed to applied epidemiological research by and for industry partners, federal stakeholders, and international health organizations.
Program faculty (Department of Epidemiology)
M Alan Brookhart
Deputy Program Leader
Charles L. Poole
Collaborating faculty (UNC)
Christy Avery (Department of Epidemiology)
Tim Carey (Sheps Center for Health Services Research)
Bill Carpenter (Health Policy and Management)
Steve Cole (Department of Epidemiology)
Alan Ellis (Sheps Center for Health Services Research)
Gang Fang (Eshelman School of Pharmacy)
Joel Farley (Eshelman School of Pharmacy)
Steve Marshall (Department of Epidemiology)
Steve Meshnick (Department of Epidemiology)
William C. Miller (Department of Epidemiology)
Kari E. North (Department of Epidemiology)
Betsy Sleath (Eshelman School of Pharmacy)
Jennifer Smith (Department of Epidemiology)
Annelies Van Rie (Department of Epidemiology)
Eric Whitsel (Department of Epidemiology)
Pharmacoepidemiology Training at UNC
To complement students' academic skills, faculty advisors in the program work with students to identify internship opportunities for gaining first-hand experience in pharmacoepidemiology practice within federal and international agencies, pharmaceutical companies and research organizations.
In addition to the coursework available, pharmacoepidemiology faculty and students meet twice monthly to discuss recent pharmacoepidemiology methods and share current research projects. UNC also has an active student chapter of the International Society for Pharmacoepidemiology (ISPE) and helps to coordinate the annual Harry Guess Memorial Lecture in Pharmacoepidemiology.
|Last updated May 02, 2013|